Jeff Reese Archives
Study seeks to explore drug link to fetal vessel defect
Aug. 18, 2022—Vanderbilt researchers have received a grant to study whether drugs given to premature infants in the neonatal intensive care unit (NICU) contribute to a potentially lethal condition called patent ductus arteriosus.
Six Vanderbilt faculty elected as 2020 fellows of the AAAS
Dec. 3, 2020—Six Vanderbilt University faculty members have been elected 2020 fellows of the American Association for the Advancement of Science, an honor bestowed upon AAAS members by their peers.
Celebration honors new holders of endowed chairs at Vanderbilt
Mar. 2, 2017—Ten Vanderbilt University faculty members named to endowed chairs were honored Tuesday during a celebration at the Student Life Center. Their academic achievements range from imaginative scholarship on economics and development to groundbreaking discoveries about the role of DNA in memory formation.
Therapies to prevent preterm birth
Feb. 9, 2016—Vanderbilt researchers have developed a high-throughput assay that will aid in identifying new compounds to treat preterm labor or postpartum bleeding.
Antibiotics, fetal vessel defect linked
Oct. 15, 2014—Certain antibiotics increase the risk of a congenital heart disorder called patency of the ductus arteriosis.
Development and disease in the aorta
Apr. 2, 2014—Smooth muscle cells that line the aorta differ in development but not in the adult, a finding that has implications for understanding aortic development and disease.
Antacids: risky for premature babies
Jun. 12, 2013—Antacids that block a certain enzyme pose a risk for a common cardiac problem in premature infants.